BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24574344)

  • 1. Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia.
    Spinetti G; Specchia C; Fortunato O; Sangalli E; Clerici G; Caminiti M; Airoldi F; Losa S; Emanueli C; Faglia E; Madeddu P
    Diabetes Care; 2014 May; 37(5):1410-7. PubMed ID: 24574344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality after major amputation in diabetic patients with critical limb ischemia who did and did not undergo previous peripheral revascularization Data of a cohort study of 564 consecutive diabetic patients.
    Faglia E; Clerici G; Caminiti M; Curci V; Clerissi J; Losa S; Casini A; Morabito A
    J Diabetes Complications; 2010; 24(4):265-9. PubMed ID: 19328013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34
    Spinetti G; Sangalli E; Tagliabue E; Maselli D; Colpani O; Ferland-McCollough D; Carnelli F; Orlando P; Paccagnella A; Furlan A; Stefani PM; Sambado L; Sambataro M; Madeddu P
    Diabetes Care; 2020 Jul; 43(7):1520-1529. PubMed ID: 32358022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Postoperative Percutaneous Coronary Intervention, Pharmacologic Treatment, and Predisposing Factors on Clinical Outcomes in Patients With and Without Type 2 Diabetes Along With Critical Limb Ischemia.
    Lee CY; Wu TC; Lin SJ
    Clin Ther; 2021 Jan; 43(1):195-210.e2. PubMed ID: 33358255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of demographic and clinical characteristics, revascularization feasibility, major amputation, and mortality rate in diabetic patients admitted to a tertiary diabetic foot center for critical limb ischemia: comparison of 2 cohorts recruited at a 10-year distance.
    Faglia E; Clerici G; Scatena A; Caminiti M; Curci V; Prisco M; Prisco V; Greco R; Cetta F; Morabito A
    Ann Vasc Surg; 2014 Oct; 28(7):1729-36. PubMed ID: 24952297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study.
    Faglia E; Clerici G; Clerissi J; Gabrielli L; Losa S; Mantero M; Caminiti M; Curci V; Quarantiello A; Lupattelli T; Morabito A
    Diabetes Care; 2009 May; 32(5):822-7. PubMed ID: 19223609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic.
    Uccioli L; Gandini R; Giurato L; Fabiano S; Pampana E; Spallone V; Vainieri E; Simonetti G
    Diabetes Care; 2010 May; 33(5):977-82. PubMed ID: 20200304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction.
    Fortunato O; Spinetti G; Specchia C; Cangiano E; Valgimigli M; Madeddu P
    Cardiovasc Res; 2013 Nov; 100(2):192-200. PubMed ID: 23761401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of foot infection on infrainguinal bypass outcomes in patients with chronic limb-threatening ischemia.
    Mayor JM; Valentin W; Sharath S; Barshes NR; Chung J; Kougias P; Mills JL
    J Vasc Surg; 2018 Dec; 68(6):1841-1847. PubMed ID: 30064844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Progenitor Cells May Be Related to Major Amputation after Angioplasty in Patients with Critical Limb Ischemia.
    Santillán-Cortez D; Vera-Gómez E; Hernández-Patricio A; Ruíz-Hernández AS; Gutiérrez-Buendía JA; De la Vega-Moreno K; Rizo-García YA; Loman-Zuñiga OA; Escotto-Sánchez I; Rodríguez-Trejo JM; Téllez-González MA; Toledo-Lozano CG; Ortega-Rosas T; García S; Mondragón-Terán P; Suárez-Cuenca JA
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients.
    Faglia E; Clerici G; Clerissi J; Gabrielli L; Losa S; Mantero M; Caminiti M; Curci V; Lupattelli T; Morabito A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):484-90. PubMed ID: 16730466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
    Moazzami K; Lima BB; Hammadah M; Ramadan R; Al Mheid I; Kim JH; Alkhoder A; Obideen M; Levantsevych O; Shah A; Liu C; Bremner JD; Kutner M; Sun YV; Waller EK; Hesaroieh IG; Raggi P; Vaccarino V; Quyyumi AA
    JAMA Cardiol; 2020 Feb; 5(2):147-155. PubMed ID: 31799987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection.
    Meloni M; Izzo V; Giurato L; Brocco E; Ferrannini M; Gandini R; Uccioli L
    J Diabetes Res; 2019; 2019():4312737. PubMed ID: 31485450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Revascularization has a Significant Impact on Limb Salvage Rate and Wound Healing for Patients with Diabetic Foot Ulcers: Single-Centre Retrospective Analysis with a Multidisciplinary Approach.
    Caetano AP; Conde Vasco I; Veloso Gomes F; Costa NV; Luz JH; Spaepen E; Formiga A; Coimbra É; Neves J; Bilhim T
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1449-1459. PubMed ID: 32743744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia.
    Awad S; Karkos CD; Serrachino-Inglott F; Cooper NJ; Butterfield JS; Ashleigh R; Nasim A
    Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):51-9. PubMed ID: 16488631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival evaluation of the patients with diabetic major lower-extremity amputations.
    Gök Ü; Selek Ö; Selek A; Güdük A; Güner MÇ
    Musculoskelet Surg; 2016 Aug; 100(2):145-8. PubMed ID: 26965501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers.
    Panunzi A; Madotto F; Sangalli E; Riccio F; Sganzaroli AB; Galenda P; Bertulessi A; Barmina MF; Ludovico O; Fortunato O; Setacci F; Airoldi F; Tavano D; Giurato L; Meloni M; Uccioli L; Bruno A; Spinetti G; Caravaggi CMF
    Cardiovasc Diabetol; 2022 Sep; 21(1):196. PubMed ID: 36171587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions.
    Scatena A; Petruzzi P; Ferrari M; Rizzo L; Cicorelli A; Berchiolli R; Goretti C; Bargellini I; Adami D; Iacopi E; Del Corso A; Cioni R; Piaggesi A
    Int J Low Extrem Wounds; 2012 Jun; 11(2):113-9. PubMed ID: 22665920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia.
    Castronuovo JJ; Adera HM; Smiell JM; Price RM
    J Vasc Surg; 1997 Oct; 26(4):629-37. PubMed ID: 9357464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for lower extremity amputation in patients with diabetic foot].
    Xu B; Yang CZ; Wu SB; Zhang D; Wang LN; Xiao L; Chen Y; Wang CR; Tong A; Zhou XF; Li XH; Guan XH
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):24-28. PubMed ID: 28056319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.